Novartis https://www.reuters.com/markets/companies/NOVN.S” target=”_blank” rel=”noopener”>(NOVN.S) on Tuesday raised its full-year earnings forecast for the second time on strong drug sales and mapped out the planned separation and stock market debut of its gen…
Read More
Previous ArticleRobinhood Eyes UK Market with New Hirings Already Underway